Status:
COMPLETED
Controlled Study of ONO-1101 in Patients With Postoperative Tachyarrhythmias in Japan
Lead Sponsor:
Ono Pharmaceutical Co. Ltd
Conditions:
Postoperative Supraventricular Tachyarrythmia
Eligibility:
All Genders
21-84 years
Phase:
PHASE2
PHASE3
Brief Summary
The purpose of this study is to evaluate the efficacy and safety of ONO-1101 in postoperative supraventricular tachyarrhythmias.
Eligibility Criteria
Inclusion
- 20 years or older
- Postoperative supraventricular tachyarrhythmias
- Within 7 days postoperatively
- Other inclusion criteria as specified in the protocol
Exclusion
- Acute myocardial infarction (within 1 month after onset)
- Severe heart failure \[New York Heart Association (NYHA) functional class III or higher\]
- Atrioventricular block (grade II or higher), or sick sinus syndrome
- Other exclusion criteria as specified in the protocol
Key Trial Info
Start Date :
June 1 2001
Trial Type :
INTERVENTIONAL
End Date :
Estimated Enrollment :
165 Patients enrolled
Trial Details
Trial ID
NCT00212654
Start Date
June 1 2001
Last Update
October 11 2012
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.